Malaria transmission-blocking vaccines—how can their development be supported?
View/ Open
Date
03/2000Author
Carter, Richard
Mendis, Kamini N
Miller, Louis H
Molineaux, Louis
Saul, Allan
Metadata
Abstract
Malaria is a disease of poor countries. The development of malaria vaccines requires considerable investment, for
which there is little commercial interest, particularly for transmission-blocking vaccines that have the
public health objective of protecting communities from the spread of malaria rather than protecting
individuals from the disease. Here, Carter et al. summarize the report of a committee of experts on the
relevance and prospects for these vaccines.